EVO PHARMA
Timeline
21 events since 2006Filings
Financial
End
20062008201020122014201620182020202220242026
2020
Annual accounts 2019 filed PDFfull format · 36 days before the deadline
Deed on restructuring and the end PDF
2019
Back to profit net €388,283 The net result is €388,283, after 7 loss-making years.
Liquidity times 50 current ratio 3.98 The current ratio rises from 0.08 to 3.98. Short-term debt falls from €193,248 to €147,811.
Equity above €100,000 equity €122,676 Equity rises from -€265,607 to €122,676.
Annual accounts 2018 filed PDFfull format · 68 days before the deadline
2018
Annual accounts 2017 filed PDFfull format · 50 days before the deadline
2017
Annual accounts 2016 filed PDFfull format · 33 days before the deadline
2016
Annual accounts 2015 filed PDFfull format · 6 days before the deadline
2015
Annual accounts 2014 filed PDFfull format · 38 days before the deadline
2014
Weakest financial year net -€80,996 The net result drops to -€80,996, the lowest from 2007 to 2019.
Annual accounts 2013 filed PDFfull format · 64 days before the deadline
2013
Liquidity more than doubled current ratio 1.70 The current ratio rises from 0.80 to 1.70. Short-term debt falls from €552,052 to €414,915.
Annual accounts 2012 filed PDFfull format · 41 days before the deadline
2012
Annual accounts 2011 filed PDFfull format · 3 days late
2011
Annual accounts 2010 filed PDFfull format · 86 days before the deadline
2010
Back to profit net €980 The net result is €980, after one loss-making year.
Annual accounts 2009 filed PDFfull format · 20 days late
2009
Annual accounts 2008 filed PDFfull format · 39 days before the deadline
2008
Annual accounts 2007 filed PDFfull format · 31 days before the deadline
2006
Incorporation PDF12 publications in the Belgian Official Gazette, the last on 25-05-2020
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank